Gram-positive bacteria process and release small peptides or "pheromones" that act as signals 27 for the induction of adaptive traits including those involved in pathogenesis. One class of small 28 signaling pheromones is the cyclic auto-inducing peptides (AIPs), which regulate expression of 29 genes that orchestrate virulence and persistence in a range of microbes including 30
49
Introduction 51
Quorum sensing in Gram-positive bacteria occurs via the maturation and release of small 52 signaling oligopeptides (1). These peptides can be linear, but may also undergo cyclic ring 53 formation, as is known to occur with the Staphylococcus aureus auto-inducing peptide, AIP (2, 54
3). In either scenario, a precursor peptide is synthesized and processed prior to, or after export 55 6 investigated in great detail, at least one other study has implicated a type-II CAAX protease in 126 the regulation of virulence gene expression. The CAAX protease of Group B Streptococcus, 127
Abx1, acts as a regulator of the CovSR two-component system through its histidine kinase 128
CovS, where overexpression of Abx1 promotes activation of CovS (58). Thus, there is 129 mounting evidence for a conserved function of type-II CAAX proteases in the regulation of two-130 component system signaling in bacteria, which in these two instances appears to operate 131 through interaction with a histidine kinase and is independent of catalytic activity. 132
In this work, we report the identification of SAUSA300_1984, named Membrane Protease 133
Regulator of Agr Quorum Sensing, MroQ. We determine that MroQ promotes TLR2-mediated 134 activation of innate immune cells while preventing induction of IL-1β by primary murine 135 macrophages in vitro. This altered inflammatory profile is recapitulated in in vivo infection 136 models where MroQ promotes inflammatory pathology, cytokine secretion, and bacterial 137 persistence in a model of skin and soft tissue infection. Further investigation into the mode of 138 action of MroQ determined that it acts to regulate the activity of the Agr quorum sensing 139 system as evidenced by reduced secreted virulence factors and increased surface protein 140 expression in a ΔmroQ mutant. Our data suggest that MroQ may interface with the Agr system 141 at the level of peptide processing or transport to blunt activation of the AgrC/A two-component 142 system, which remains otherwise responsive in a ΔmroQ mutant background. Altogether, our 143 data support a model whereby MroQ controls gene expression at the level of the Agr system, 144 with significant impacts on the virulence potential of S. aureus. 145 146
Results 147
MroQ is a predicted type-II CAAX protease that blunts TLR2-mediated recognition of S. 148 aureus by macrophages. The mroQ open reading frame is located within the core genome of 149 7 The gene is flanked by sdrH and groEL/ES, which encode the serine aspartate repeat family 151 protein SdrH (59) and the GroEL/ES stress response chaperone system (60) respectively (Fig  152   1A ). Phyre2 prediction software analysis of the MroQ amino acid sequence suggest a topology 153 containing seven transmembrane helices with the N-terminus positioned in the cytosol and C-154 terminus in the extracellular space, though the weaker predictive strength of the topology 155 analysis at the N and C-terminus may suggest alternative arrangements in the membrane (Fig  156   1B) . Consistent with its annotation as a type-II CAAX protease, MroQ contains a conserved 157 diglutamate motif EEXXXR (E141-E142) and FXXXH (H180) metal coordination motif that 158 shares sequence identity with previously characterized CAAX proteases SpdA and SpdB, with 159 weaker conservation compared to SpdC, which is unlikely to have catalytic activity ( Fig 1C) . 160
We previously determined that supernatant derived from a SAUSA300_1984 transposon 161 insertion mutant compromises macrophage activation (47). To begin interrogating the function 162 of MroQ in greater detail, we first generated an in-frame deletion mutant and complementation 163 strain that expresses mroQ from an ectopic site in the S. aureus chromosome driven by its 164 predicted native promoter (61). WT, ΔmroQ, and ΔmroQ + mroQ strains replicate identically in 165 tryptic soy broth (TSB) and Roswell Park Memorial Institute (RPMI) medium ( Fig S1A-B ). We 166 found that similar to the transposon insertion mutant, supernatant derived from a ΔmroQ 167 mutant enhanced production of IL-1β by murine bone marrow macrophages (BMM), but 168 reduced production of the inflammatory cytokine, IL-6, and the neutrophil chemotactic factor, 169 KC ( Fig 1D) . The perturbations in IL-6 and KC production were dependent on Toll-like receptor 170 (TLR) mediated recognition of S. aureus, as evidenced by elimination of IL-6 and KC 171 production in MyD88 -/and TLR2 -/macrophages, but not TLR4 -/macrophages ( Fig 1D and  172 S2A-B). In contrast, the enhanced IL-1β production did not depend on TLRs (Fig 1D and S2A-173 B). These data indicate MroQ bears similarities to type-II CAAX proteases, is positioned in 174 close proximity to the agr locus in the S. aureus chromosome, and perturbs the activation of 175 innate immune cells in culture through both TLR-dependent and independent mechanisms. 176 177 MroQ is required for S. aureus virulence. 178
Given the dramatic effect of the ΔmroQ mutant on macrophage activation and the predicted 179 effects this might have on the inflammatory milieu during infection, we reasoned that the 180 mutant would be compromised for virulence. To test this possibility, we infected mice 181 intradermally with WT, ΔmroQ, and ΔmroQ + mroQ strains. There were no differences in 182 bacterial CFU between strains at 72 hours post-infection ( Fig S3A) . However, significant 183 dermonecrosis was evident in mice infected with WT and ΔmroQ + mroQ strains, but not those 184 infected with the ΔmroQ mutant ( Fig S3B) . Consistent with reduced inflammatory tissue 185 damage, mice infected with a ΔmroQ mutant showed significantly reduced levels of the 186 inflammatory chemokine MCP-1 and trends toward reduced levels of IL-6, KC, CCL3, and 187 CCL4 at 72 hours ( Fig S3C) . At 120 hours post-infection, 10-fold fewer CFU were recovered 188 from the abscesses of mice infected with a ΔmroQ mutant (Fig 2A) . Gross pathological signs 189 of disease including large, ruptured, dermonecrotic abscesses were not observed in ΔmroQ 190 mutant-infected mice and the abscesses remained closed with little evidence of inflammation 191 ( Fig 2B) . There were significant reductions in IL-6, KC, MCP1, and CCL3 at the abscess site, 192 consistent with in vitro studies using BMM ( Fig 1D and 2C) . IL-1β levels were equally elevated 193 in all infection conditions compared to 72 hours ( Fig 2C and S3C) . These data indicate that 194
MroQ is important for S. aureus skin and soft tissue infection. 195
196
A ΔmroQ mutant phenocopies a Δagr mutant. 197 mroQ was identified in a screen that used secreted factors to probe innate immune cell 198 activation (47). Therefore, we sought to test if a ΔmroQ mutant had notable differences in its 9 secretome that might explain BMM activation defects and reduced virulence. Exoprotein profile 200 analysis indicated the levels of secreted proteins are reduced in ΔmroQ mutant supernatants 201 ( Fig 3A) . This defect in protein secretion closely resembled the profiles of a S. aureus strain 202 with a deletion of the agr locus, Δagr ( Fig 3A) . Exoprotein analysis of a ΔmroQ Δagr double 203 mutant revealed identical profiles to that of either a ΔmroQ or Δagr deletion ( Fig 3A) . 204 Furthermore, ΔmroQ, Δagr, and ΔmroQ Δagr supernatants induced BMM production of IL-1β, 205 but led to reduced levels of IL-6 and KC with the same observed dependency on TLR2 ( Fig 3B  206 and S4A-C). Incidentally, both mroQ and agrB transposon insertion mutants were identified as 207 inducers of IL-1β secretion in our prior transposon mutant library screen (47). 208
Given the similarities between ΔmroQ and Δagr mutants for defects in protein secretion and 209 secreted factor-mediated perturbations in macrophage activation, we sought to determine 210 whether or not a ΔmroQ mutant exhibits other common phenotypes associated with a Δagr 211 mutant. The Agr system regulates toxin secretion and surface protein production (3). 212 Therefore, we compared the levels of lytic toxins and Agr-regulated surface protein, Protein A, 213 between ΔmroQ and Δagr mutants (3, 62). We found that toxins leukocidin AB (LukA), Panton-214
Valentin leukocidin (LukS-PV), and alpha-hemolysin (Hla), were reduced in abundance in a 215
ΔmroQ and Δagr mutant, while surface Protein A levels were increased ( Fig 4A) . Indeed, a 216 prior transposon mutagenesis screen for deficiencies in hemolytic activity, conducted by Fey et 217 al, also identified SAUSA300_1984 as a gene important for Hla production (63). Consistent 218 with these observations, ΔmroQ and Δagr mutants exhibited significantly reduced hemolytic 219 activity compared to WT and ΔmroQ + mroQ strains ( Fig 4B) and both strains were similarly 220 attenuated in a murine intradermal infection model ( Fig 4C) . In summary, MroQ appears to be 221 required for Agr function in some unknown way. 222 223 A ΔmroQ mutant is compromised for AIP processing or export. MroQ is a hypothetical 224 type-II CAAX metalloprotease. Despite the clear connections between Agr and S. aureus 225 pathobiology, there exists key gaps in our knowledge of the mechanics of Agr system 226 activation ( Fig 5A) (5, 64). Most notably: (i) the complete range of proteins needed for 227 maturation of AgrD have not been fully elucidated; (ii) a dedicated transporter for AIP or its 228 leader peptide has not been conclusively identified; and (iii) differential processing of AIPs I-IV 229 has not been investigated. We wondered if the function of MroQ within the Agr system might 230 be to facilitate processing and/or export of the AgrD precursor peptide to generate AIP, or if it 231 promotes function of the histidine kinase AgrC in a manner similar to SpdC and WalK ( Fig 5A) . 232
To test these possibilities, we first introduced a reporter plasmid that drives the expression of 233 GFP via an AgrA-regulated promoter known as P3 (pDB59-P3-gfp) into ΔmroQ and Δagr 234 mutant strains (65). We collected conditioned medium from early stationary phase cultures 235 (AIP production is high) of WT, ΔmroQ, ΔmroQ + mroQ and Δagr strains and applied them to 236 the reporter strains, followed by measurement of GFP fluorescence. Conditioned medium 237 derived from all strains tested on the Δagr + pDB59-P3-gfp reporter strain did not induce 238 promoter activation ( Fig 5B) . This was expected because the Δagr mutant lacks all 239 components of the Agr system, including those that transmit the AIP signal (AgrC and AgrA). 240
In contrast, when conditioned medium from WT or ΔmroQ + mroQ strains was added to the 241 ΔmroQ + pDB59-P3-gfp reporter strain, we observed a significant increase in fluorescence 242 intensity indicating the AgrC-AgrA signaling axis is intact and able to recognize AIP. However, 243 conditioned medium from ΔmroQ and Δagr mutants were unable to induce P3 promoter 244 activity in this reporter strain background ( Fig 5B) . Similarly, introduction of the pDB59-P3-gfp 245 reporter into ΔagrB and ΔagrB ΔmroQ strains followed by addition of conditioned medium 246 (CM) derived from WT S. aureus showed no difference in the ability to transmit signal through 247
AgrC and AgrA ( Fig 5C) . These data suggest the Agr system defect in a ΔmroQ mutant does 248 not occur at the level of AgrC or its ability to propagate signal to AgrA. 249
The absence of a clear effect of MroQ on AgrC signaling lead us to interrogate whether or 250 not MroQ affects AgrD protein processing/export. We generated a plasmid that expresses 251
AgrD-6xHis under the control of a constitutive promoter (pOS1-P sarA -agrD-6xHis) (66, 67). The 252 plasmid was introduced into WT, ΔmroQ, ΔmroQ+mroQ, and Δagr strains. It is known that 253 unprocessed AgrD accumulates in the absence of the AgrB peptidase, indicating that 254 processing of AgrD by AgrB precedes export (3, 27-30). We hypothesized that if MroQ is 255 involved in promoting an AgrD processing event similar to that of AgrB, then we should detect 256 full length AgrD-6xHis in the ΔmroQ mutant. Indeed, full length AgrD-6xHis was detectable 257 when expressed in the ΔmroQ and Δagr strains ( Fig 5D) . To further determine if MroQ is 258 involved in regulating AgrBD functions related to AIP processing/export, we generated a 259 plasmid that constitutively expresses agrBD driven by the synthetic promoter, P HELP , and 260 introduced this plasmid (pOS1-P HELP -agrBD) into Δagr or Δagr ΔmroQ strains followed by 261 determination of whether or not conditioned medium derived from these strains is able to 262 activate the pDB59-P3-gfp reporter in a ΔagrB or Δagr mutant background. We found that 263 conditioned medium derived from the Δagr ΔmroQ + pOS1-P HELP -agrBD exhibited a 30% 264 reduction in P3 promoter activity compared to conditioned medium derived from the Δagr + 265 pOS1-P HELP -agrBD strain ( Fig 5E) . These data support the hypothesis that MroQ plays a role 266 in promoting the functionality of the AgrB-AgrD peptide processing/export axis of the Agr The type-II CAAX protease family of enzymes is conserved in both prokaryotes and 271 eukaryotes. In eukaryotes, proteolytic activity occurs at a CAAX motif on the C-terminal end of target proteins, ultimately leading to lipidation. In bacteria, the functions of the CAAX protease 273 family members are not as clear, but some proteins in this family use proteolytic activity to 274 confer immunity against bacteriocins (68), while others engage in intramembrane proteolysis 275 events to promote adaptive traits (52, 69). Of the three additional characterized CAAX 276 protease enzymes in S. aureus (SpdA-C), the proteolytic activity of the enzyme does not 277 appear to be required for function. This is also true of the Abx1 enzyme of Group B 278
Streptococcus. Thus, the CAAX proteases of bacteria appear to have diverse functions, some 279 of which depend on proteolytic activity and others that do not. To test if the active site of MroQ 280 is required to promote AgrBD activity, we introduced mutations into the conserved CAAX 281 protease amino acid residues within the EEXXXR and FXXXH motifs previously determined to 282 be required for enzymatic activity in a range of type-II CAAX proteases (50, 52, 68, 70, 71). 283
Alanine substitutions were introduced at E141, E142, and H180 followed by expression of 284 point mutants in single copy under the control of the mroQ native promoter in ΔmroQ S. aureus 285 ( Fig. 6A ). As evidenced by immunoblot analysis, the expression of MroQ(E141A) was unable 286 to complement alpha toxin secretion defects, whereas MroQ(E142A) and MroQ(H180A) 287 exhibited some restoration in alpha toxin production by immunoblot, with MroQ(E142A) 288 supernatant containing greater amounts of alpha toxin than MroQ(H180A) (Fig. 6B ). The 289 observed differences in alpha toxin levels by immunoblot were recapitulated in hemolytic 290 activity assays where MroQ(E142A) exhibited partial restoration in hemolytic activity on rabbit 291 red blood cells, but MroQ(E141A) and MroQ(H180A) did not ( Fig. 6C ). Consistent with the 292 observed effects on alpha toxin secretion and hemolytic activity, MroQ(E142A) partially 293 complemented protein A production defects ( Fig. 6D ). In contrast, none of the three mutations 294 restored LukS or LukA production to an observable degree by immunoblot and the MroQ point 295 mutants failed to complement changes in macrophage activation caused by supernatant 296 derived from a ΔmroQ mutant ( Fig. 6D-E ). Together, these data suggest that conserved amino acids implicated in type-II CAAX protease activity are important for the effects of MroQ on 298 AgrBD function. Residue E141 is required for MroQ function, whereas residues E142 and 299 H180 promote optimal activity. 300 301 Investigation of the role of MroQ amino acid residues E141, E142, and H180 in Agr-302 mediated gene expression and virulence. We next sought to determine the extent with 303 which ΔmroQ mutant strains expressing MroQ(E141A), MroQ(E142A), and MroQ(H180A) alter 304 gene expression and pathogenesis. We first conducted P3 promoter activation analyses to 305 evaluate whether or not generation and release of functional AIP occurs in strains expressing 306 each point mutant. As anticipated, conditioned medium derived from ΔmroQ + MroQ(E141A) 307
and ΔmroQ + MroQ(H180A) were unable to appreciably activate the P3-gfp promoter fusion 308 above background levels when applied to the ΔmroQ + pDB59 reporter strain ( Fig 7A) . In 309 contrast, conditioned medium derived from ΔmroQ + MroQ(E142A) led to partial activation with 310 a greater than 10-fold increase in fluorescence intensity compared to background levels ( Many Gram-positive pathogens use small peptide signaling pathways to control the 322 expression of virulence genes. In this work, we present the discovery of a membrane-323 embedded protease that plays a major role in promoting the function of the Agr system of S. 324 aureus. Our data suggest that the abortive infectivity protein (Abi), or type-II CAAX peptidase, 325 SAUSA300_1984 (MroQ), directly interfaces with the Agr system to promote virulence factor 326 gene expression and pathogenesis in a murine skin and soft tissue infection model. Unlike 327 other type-II CAAX proteases of S. aureus and Group B Streptococcus (55, 57, 58), MroQ 328 requires its conserved active site amino acids to confer normal functionality to the Agr system. 329
Our studies to probe the location in the Agr pathway where MroQ acts indicate that the AgrC/A 330 signaling axis remains functional and that the AgrBD axis, involved in peptide maturation, is 331 likely compromised. Together, these findings expand the view of peptide-based signaling in S. 332 aureus and highlight a newly uncovered regulatory input into virulence factor gene expression 333 that dramatically affects virulence outcomes. Gram-positive pathogens of urgent clinical 334 importance including Clostridioides difficile and Enterococcus faecalis, as well as significant 335 threats to food safety such as Listeria monocytogenes each harbors Agr systems that 336 contribute to disease (72-78). Thus, this work provides insights into alternative pathways of 337 regulation of the Agr system that may extend to other Gram-positive microbes of clinical 338
importance. 339
Our studies have determined that the secreted factors derived from either a ΔmroQ or Δagr 340 mutant cause significant release of IL-1β, but low levels of other inflammatory cytokines and 341 chemokines from primary murine macrophages in culture (Fig 1) . The production of the 342 inflammatory cytokine IL-1β in superficial tissues is known to be critical for controlling skin and 343 soft tissue infection caused by S. aureus (79-83). In contrast, the production of IL-1β during 344 systemic infection is associated with increased immunopathology (84, 85). Agr-defective 345 isolates of S. aureus are routinely isolated from patients with bacteremia (64). The reason these Agr-defectives arise and their association with morbidity in bacteremia is not well 347 understood; however, the observation is recapitulated in murine infection models wherein agr 348 mutants persist in deep tissues during bacteremia (86). Some potential mechanisms behind 349 these observations have been proposed, including a role for agr-defectives in development of 350 a persister state, as well as disruption of the optimal immune environment by agr-defective 351 strains (64). Although a ΔmroQ mutant does not elicit increased production of IL-1β compared 352 to WT at the time points tested in vivo, we postulate that the reduced levels of pro- ambiguous, but at minimum must involve additional proteins for proteolytic cleavage and 361 transport (5, 32). Our data demonstrates that the putative metalloprotease, MroQ, does not 362 seem to influence the ability of the histidine kinase AgrC to transmit signal to AgrA ( Fig 5C) . 363
Thus, it does not appear that MroQ is directly regulating the activity of AgrC. This observation 364 is different from that observed for Abx1 from Group B Streptococcus or SpdC of S. aureus, 365 which are implicated in the regulation of CovS and WalK histidine kinases respectively (57, 366 58). These studies used bacterial two-hybrid assays to determine that Abx1 and SpdC interact 367
with WalK and CovS and that deletion or over-expression changes kinase activity. Aside from 368 these physical associations, no additional evidence was provided to describe how each Abi 369 protein was mediating its function, but the studies do note that SpdC negatively regulates 370 expression from its auto-regulatory circuit has allowed us to identify a defect in AIP peptide 372 production when MroQ is absent ( Fig 5E) . We find that conditioned medium derived from Δagr 373 + pOS1-P HELP -agrBD is better able to activate a P3-gfp reporter compared to conditioned 374 medium derived from Δagr ΔmroQ + pOS1-P HELP -agrBD. Importantly, the absence of MroQ 375 does not eliminate reporter activation, suggesting that either overexpression of agrBD can 376 compensate, or that MroQ activity on AgrBD is not essential for peptide maturation/release, 377 rather it improves its efficiency in some way. Thus, MroQ appears to behave differently from 378
Abx1 and SpdC, where it acts to promote functionality of the peptide maturation module of Agr 379 and is important for the optimal generation or export of AIP in the Type I Agr MRSA strain LAC. 380
We do not yet know precisely how MroQ is mediating its effects on the AgrBD module, 381 however a ΔmroQ mutant does not release appreciable amounts of active AIP (Fig 5 and 7 ) 382 and harbors increased amounts of unprocessed cytosolic AIP ( Fig 5D) . It is notable that 383 although a ΔmroQ mutant closely resembles a Δagr mutant, there appears to be some low-384 level intrinsic activation of the Agr system in a ΔmroQ mutant as evidenced by P3 promoter 385 activity that rises above levels of a Δagr mutant (Figs 5C and 7A). This observation indicates 386 that mature AIP is at least capable of being produced by a ΔmroQ mutant, though at low 387 levels. Taken together, we propose MroQ promotes efficient AgrD proteolytic processing, 388 transport, or both. This may occur through direct effects on AgrB function or on the AgrD 389 peptide itself. We are currently exploring these possibilities. for MroQ in strains that harbor each of the four Agr alleles (data not shown). Therefore, we suspect that either the activity of MroQ on the Agr system is broad and not influenced by Agr 397 Type, or that alternative enzymes, perhaps other CAAX proteases, modulate the functions of 398 different Agr types. Given the strict dependency on the length and amino acid composition of 399 the N-terminal tails of AIP for signaling and given that precise peptide cleavage at the N-400 terminus is a requisite for activity, we favor the possibility that additional peptidases may 401 promote full maturation or export of these AIP sequence variants (39). 402
One important difference noted in the function of MroQ, compared to that of other type-II 403 CAAX proteases in S. aureus is that conserved active site residues appear to be important for 404 the activity of MroQ, but not for the CAAX proteases SpdA-C, or Group B Streptococcus Abx1. 405
This represents an additional departure from the models put forth by these CAAX proteases 406
and suggests that MroQ may alternatively function in a way that is similar to that of proteases 407 whose activities involve peptide hydrolysis or intramembrane proteolysis (50, 52, 68, 70, 71). 408
Thus far we know that the glutamate at position 141 is critical for MroQ function, whereas 409 mutations of glutamate at position 142 and the histidine at position 180 do not confer complete 410 null phenotypes. In other Abi proteins, the second glutamic acid in the EEXXXR motif is usually 411 essential for activity, an observation that is contrary to what was observed for MroQ. While 412 E142A and H180A mutations confer a partial restoration in Agr activity, only the E141A point 413 mutation is attenuated in vivo to the same level as a ΔmroQ or Δagr mutant during skin and 414 soft tissue infection. This outcome suggests that partial Agr activity conferred by expression of 415 MroQ(E142A) and MroQ(H180A), but not MroQ(E141A), is sufficient to confer normal infection 416
kinetics. 417
Altogether, this work has expanded our understanding of the regulatory inputs that dictate 418 cyclic peptide quorum sensing in S. aureus. Our studies represent an expansion of the Agr 419 regulatory circuit that may have broad impacts on therapeutic design for non-complicated 420 infection (12, 14, 87-89). Further, the work highlights the complexities of peptide based signaling and the adaptive traits that promote virulence in S. aureus. Our knowledge of the 422 activities of proteins from the Abi protein family in Gram-positive pathogens remains in its 423 infancy. This work adds to the growing compendium of work on this protein class and their 424 diverse range of functions, some of which are crucial for Gram-positive bacterial virulence. 425 426
Materials and Methods 427
Bacterial strains and culture conditions. S. aureus LAC (AH-1263) was used as the wild 428 type (WT) strain for the experiments in this study. LAC (AH-1263) is a S. aureus USA300 429 clinical isolate cured of its plasmids (90). All other bacterial strains used in this work are 430 described in Table 1 . Most recombinant plasmids were passaged through E. coli DH5α before 431 propagation in S. aureus. When constructing complementation plasmids harboring the mroQ 432 gene, we found that mroQ exhibited signs of toxicity in E. coli, resulting in a high frequency of 433 secondary mutations in the coding sequence. As an alternative, E. coli BH10C was used as a 434 host strain; BH10C reduces copy number of plasmids to near single-copy levels to limit the 435 abundance of potentially toxic genes in E. coli and reduces the likelihood of mutations (91). 436
After passage through E. coli, S. aureus RN4220 and RN9011 (RN4220+pRN7023) (61) were 437 used as intermediate strains, followed by electroporation or transduction into AH-1263 or its 438 isogenic mutant derivatives. All E. coli strains were grown in Lysogeny Broth (LB) (Amresco), 439 while S. aureus strains were grown in either Tryptic Soy Broth (TSB) (Criterion) or Roswell 440
Park Memorial Institute medium (RPMI) (Corning) supplemented with 1% casamino acids 441 (Amresco) and 2.4 mM Sodium bicarbonate (Amresco). When necessary, media were 442 supplemented with antibiotics at the following concentrations: ampicillin (Amp), 100 μg/mL; 443 erythromycin (Erm), 5 μg/mL; chloramphenicol (Cm), 10 μg/mL; anhydrous tetracycline (AnTet) 444 (Acros Organics), 1 μg/mL; and tetracycline (Tet) at 10 μg/mL (Amresco and Acros Organics). 445 growth was monitored using a Genesys 10S UV-Vis spectrophotometer by measuring culture 447 optical density at 600 nm (OD600) (Thermo). MgCl2 (pH 7.5)) and 2.5 μL of a lysostaphin (Ambi Products) stock (2 mg/mL) to achieve a 453 final concentration of 25 μg/mL. Samples were incubated at 37°C for 15 minutes to digest the 454 cell wall of S. aureus, followed by centrifugation at 14000 rpm for 5 minutes to pellet bacteria. 455
Supernatants were discarded and the genomic DNA was isolated using a Wizard Genomic 456 DNA purification kit (Promega). PCR was performed in a FlexID Mastercycler (Eppendorf) 457
using Phusion High-Fidelity DNA Polymerase (New England Biolabs) or GoTaq DNA 458 Polymerase (Promega) and dNTPs (Quanta BioSciences). For all PCR reactions 459 oligonucleotides were ordered from Eurofins (see Table 2 ). Electrophoresis of DNA samples 460 was performed in 0.8% agarose (Amresco) gels. DNA digestions were performed using the 461 following restriction endonucleases: XhoI, BamHI, EcoRI, KpnI, XbaI, SacI and PstI (New 462
England Biolabs) following the manufacturer's suggested protocols and all digested plasmids 463 were subsequently treated with Shrimp Alkaline Phosphatase (Amresco). Ligations were 464 performed using T4 DNA Ligase (New England Biolabs) and were incubated in an Eppendorf 465
ThermoMixer at 16°C overnight. When necessary, PCR purification and DNA gel extraction 466 was carried out using QIAGEN QIAquick kits. 467
To isolate plasmids from S. aureus, 5 mL overnight cultures of bacteria were grown in TSB 468 at 37°C with shaking at 200 rpm. The next day, bacteria were pelleted by centrifugation at 469 4200 rpm for 15 minutes and resuspended in 400 μl TSM buffer containing 20 μl of lysostaphin 470 stock solution (2 mg/mL) to achieve a final concentration of 0.1 mg/mL. Samples were incubated for 10 minutes at 37°C to digest the cell wall, followed by centrifugation at 13000 472 rpm for 2 minutes to pellet the bacterial cells. Thereafter, a Qiagen miniprep kit was used to 473 isolate plasmid DNA. DNA was eluted with sterile water in all cases. DNA sequencing was 474 performed by Genscript or Genewiz. 475 476 Bacteriophage-mediated generalized transduction. Transduction was used to transfer 477 stably integrated complementation plasmids between strains, as well as to mobilize marked 478 mutations within the S. aureus chromosome (Δagr::tet). S. aureus-specific bacteriophages ϕ11 479 or 80α were used in this study. Donor strains were grown overnight in 3 mL of TSB/LB (1:1) 480 supplemented with 5 mM calcium chloride (CaCl 2 ) (Amresco) and 5 mM magnesium sulfate 481 (MgSO 4 ) (Amresco) at 37°C with shaking at 200 rpm. The next day, overnight cultures were 482 diluted 1:100 in 10 mL fresh TSB/LB (1:1) supplemented with 5 mM CaCl 2 and 5 mM MgSO 4 . 483
Samples were grown for ~3 hours at 37°C with shaking at 200 rpm until reaching an OD600 of 484 0.3 -0.9. To package donor DNA into transducing phage, 100 μL of 10-fold serial dilutions (10 -485 1 to 10 -10 ) of bacteriophage stock in TMG (10 mM Tris pH 7.5, 5 mM MgCl 2 , 0.01% gelatin 486
(v/v)) were added to 15 mL conical tubes and incubated with 500 μL of the donor S. aureus 487 culture. The phage-bacteria mixture was gently vortexed and incubated at room temperature 488 for 30 minutes. 2.5 mL of melted and cooled CY top agar (casamino acids 5 g/L, yeast extract 489 5 g/L, glucose 5 g/L, NaCl 6 g/L, 7.5 g/L agar) supplemented with 5 mM CaCl 2 and 5 mM 490
MgSO 4 was added to the bacteria-phage mixture and immediately poured onto TSA plates 491 followed by incubation overnight at 30°C. The following day, phage were harvested from two to 492 three plates with confluent plaques. Bacteriophage stocks were stored at 4°C. 493
To transduce plasmids and marked mutations, recipient strains were first grown overnight in 494 20 mL of TSB/LB (1:1) supplemented with 5 mM CaCl 2 at 37°C. Samples were then 495 centrifuged for 15 minutes at maximum speed, supernatants were discarded, and bacterial pellets suspended in 3 mL of CY medium (casamino acids 5 g/L, yeast extract 5 g/L glucose 5 497 g/L NaCl 6 g/L) supplemented with 5 mM CaCl 2 . Four infection conditions were set up with 498 either bacteria alone (mock) or 10-fold serial dilutions of bacteria infected with 100 μL of 499 bacteriophage stock containing donor DNA. Tubes were mixed by inverting every ten minutes 500 for 30 minutes at room temperature, followed by the addition 40 mM sodium citrate to each 501 tube and incubation for 30 minutes at room temperature. Tubes were centrifuged at maximum 502 speed for 5 minutes and washed twice in 500 μL of CY medium supplemented with 40 mM 503 sodium citrate, followed by resuspension in 200 μL of CY medium supplemented with 40 mM 504 sodium citrate and spreading onto CY agar or TSA plates containing 10 mM sodium citrate and 505 any antibiotics necessary for selection. Plates were placed at 37°C overnight. Potential 506 transductants were screened for antibiotic resistance and acquisition of desired mutations by 507 PCR and DNA sequencing. 508 509 Generation of mroQ and agrB in-frame deletion mutants. mroQ and agrB in-frame deletion 510 mutants were generated using the temperature-sensitive mutagenesis plasmid pIMAY (92). 511
For mroQ, two fragments that correspond to ~500 base pair regions of sequence homology 512 immediately upstream and downstream of mroQ were amplified. Oligonucleotides MroQ-1 and 513
MroQ-2 were used to amplify the region upstream of mroQ, while oligonucleotides MroQ-3 and 514
MroQ-4 were used to amplify the region downstream of mroQ (Table 2 ). The fragments were 515 joined by splicing by overlap extension (SOEing) PCR using oligonucleotides MroQ-1 and 516
MroQ-4 and subcloned into the multi-cloning site of pIMAY using restriction endonucleases 517
KpnI and SacI. For agrB, two fragments that correspond to ~500 base pair regions of 518 sequence homology immediately upstream and downstream of agrB were amplified. 519
Oligonucleotides agrB-1 and agrB-2 were used to amplify the region upstream of agrB, while 520 oligonucleotides agrB-3 and agrB-4 were used to amplify the region downstream of agrB (Table 2 ). The fragments were joined by splicing by overlap extension (SOEing) PCR using 522 oligonucleotides agrB-1 and agrB-4 and subcloned into the multi-cloning site of pIMAY using 523 restriction endonucleases KpnI and SacI. Mutagenesis was carried out according to our 524 previously published protocols (48, 49). PCR and DNA sequencing analysis were used to 525 determine successful generation of mutants. 526 527
Generation of ΔmroQ + mroQ, ΔmroQ + mroQ(E141A), ΔmroQ + mroQ(E142A), and 528
ΔmroQ + mroQ(H180A) complementation strains. A single copy chromosomal 529 complementation strain driving mroQ expression under its native promoter was constructed 530 using the integrative plasmid pJC1112 (61). The pJC1112-mroQ plasmid was generated by 531 PCR using oligonucleotides 37F and 37R ( Table 2 ). The resulting amplicon was then 532 subcloned into the pJC1112 vector using EcoRI and BamHI restriction endonucleases followed 533 by transformation into BH10C E. coli and electroporation into the RN9011 where the plasmid 534 integrates at the SapI1 site. The integrated complementation vector was then transduced into 535 a ΔmroQ mutant as described above. Successful introduction of the complementation 536 construct was determined by PCR and sequencing. To generate complementation strains 537 harboring amino acid substitutions in MroQ catalytic residues, primer MroQPMComp-F was 538 paired with MroQ(E141A)-2, MroQ(E142A)-2, or MroQ(H180A)-2 and primer MroQPMComp-R 539 was paired with MroQ(E141A)-3, MroQ(E142A)-3, or MroQ(H180A)-3. The resulting amplicons 540 from these two PCRs were used in a SOEing PCR with primers MroQ-PMComp-F and MroQ-541 PMComp-R followed by subcloning the product into pJC1111 using XbaI and PstI restriction 542 endonucleases followed by transformation into BH10C E. coli and electroporation into the 543 RN9011 where the plasmid integrates at the SapI1 site. The integrated complementation 544 vector was then transduced into a ΔmroQ mutant as described above. 545 Construction of Δagr::tet mutants. A marked deletion mutation of agrBDCA (Δagr::tet) was 547 transduced into AH-1263 (WT), ΔmroQ, and ΔagrB by bacteriophage-mediated transduction 548 as described above. 549 550 Construction of P3-gfp reporter strains. The pDB59 reporter plasmid contains the P3 551 promoter of the Agr system driving the expression of gfp (56). The plasmid was isolated from 552 E. coli and passaged through RN4220, followed by electroporation into WT, ΔmroQ, ΔagrB, 553
ΔagrB ΔmroQ, and Δagr::tet. 554 555
Construction of pOS1-P sarA-agrD-6xHis expression plasmid. An AgrD-6x-His expression 556
plasmid was generated by fusing the P sarA promoter linked to the S. aureus superoxide 557 dismutase (sod) ribosomal binding site (66, 67) and to the coding sequence of AgrD harboring 558 a 6x-His tag on its C-terminus. P sarA -sod RBS was amplified using primers PsarA-AgrD6xHis-1 559
and PsarA-AgrD6xHis-2 and agrD-6xHis was amplified using oligonucleotides PsarA-560
AgrD6xHis-3 and PsarA-AgrD6xHis-4. A SOEing PCR was performed to splice these 561 amplicons together using primers PsarA-AgrD6xHis-1 and PsarA-AgrD6xHis-4. The resulting 562 amplicon was cloned into pOS1 using PstI and EcoRI restriction endonucleases and the 563 product was transformed into DH5α, passaged through RN4220, and electroporated into wild 564 type, ΔmroQ, ΔmroQ+mroQ, and Δagr isogenic strains. 565 566 Construction of pOS1-P HELP -agrBD plasmid. An agrBD expression plasmid was generated 567 by fusing the P HELP promoter (48, 49, 93) to agrBD. P HELP was amplified using primers phelp-568
AgrBD-1 and phelp-AgrBD-2 and agrBD was amplified using oligonucleotides phelp-AgrBD-3 569 and phelp-AgrBD-4. A SOEing PCR was performed to splice the resulting amplicons together 570 using primers phelp-AgrBD-1 and phelp-AgrBD-4. The final amplicon was cloned into pOS1 using SalI and EcoRI restriction endonucleases and the resulting plasmid was transformed into 572 BH10C E. coli, passaged through RN4220, and electroporated into wild type, Δagr, and Δagr 573 ΔmroQ isogenic strains. 574 575 Whole cell lysate preparation. 5 mL of S. aureus strains were grown overnight at 37°C with 576 shaking at 200 rpm. Overnight cultures were diluted 1:100 in 20 mL of fresh medium and 577 allowed to replicate for an additional 8 hours at 37°C with shaking at 200 rpm. After 8 hours, 578 the OD600 was measured and samples were centrifuged at 4200 rpm for 15 minutes to pellet 579 the bacteria. Supernatants were removed and the bacterial cell pellets were stored at -80°C 580 until use. Pellets were thawed on ice and resuspended in 250 μL of PBS supplemented with 1 581 M NaCl and 6 M Urea (VWR). The resuspended bacteria were then added to screw cap 582 microcentrifuge lysing tubes (Fisher Scientific) containing 250 μL 0.1 mm glass cell disruption 583 beads (Scientific Industries, Inc.). Cells were lysed using a Fast Prep-24 5G (MP Biomedicals) 584 at speed 5.0 for 20 seconds, subsequent incubation on ice for 5 minutes, and then disrupted a 585 second time at speed 4.5 for 20 seconds. 50 μL of 6x SDS Sample buffer (0.375 M Tris pH 586 6.8, 12% SDS, 60% glycerol, 0.6 M DTT, 0.06% bromophenol blue) was added directly to 587 lysed cells and boiled for 10 minutes, followed by centrifugation at maximum speed for 15 588 minutes at 4°C. Samples were stored at -20°C for no longer then a few days. 589 590 Exoprotein preparations. S. aureus strains were grown at 37°C with shaking at 200 rpm 591 overnight. Overnight cultures were diluted 1:100 in fresh medium and allowed to grow to 592 stationary phase at 37°C with shaking at 200 rpm (~8 hours). OD600 was measured and 593 samples were centrifuged at 4200 rpm for 15 minutes. 1.3 mL of supernatants were collected 594 in 1.5 mL microcentrifuge tubes and cooled on ice for approximately 30 minutes followed by 595 addition of 150 μl of 100% trichloroacetic acid (TCA) and overnight incubation at 4°C. The next day, samples were centrifuged at maximum speed for 15 minutes at 4°C and supernatants 597 were removed and discarded. Precipitated proteins were washed with 1 mL of 100% ethanol 598 (Decon Laboratories Inc.) and incubated at 4°C for 30 minutes, followed by a 15-minute spin at 599 maximum speed at 4°C. Protein pellets were air dried at room temperature for about one hour, 600 followed by dissolving the pellet in TCA-SDS sample buffer (0.5 M Tris-HCl buffer, 4%SDS 601 mixed 1:1 with 2x SDS Sample buffer) and boiling for 10 minutes before storage at -20°C. 602 603 Immunoblot for secreted virulence factors. Wild type, ΔmroQ, ΔmroQ+mroQ, 604
ΔmroQ+mroQ(E141A), ΔmroQ+mroQ(E142A), ΔmroQ+mroQ(H180A), and Δagr strains were 605 grown in 5 mL of TSB for eight hours at 37°C with shaking at 200 rpm and supernatants were 606 collected for TCA precipitation as described above. Prior to loading, protein samples were 607 normalized based on OD600 and subsequently separated by sodium dodecyl sulfate 608 polyacrylamide gel electrophoresis (SDS-PAGE) on 12% polyacrylamide gels at 120 volts in a 609
Quadra Mini-Vertical PAGE/Blotting System (CBS Scientific). Resolved proteins were then 610 transferred from polyacrylamide gels to 0.45 μm PVDF membranes (Immobilon, Roche) at 200 611 V for 1 hr. After transfer, membranes were stored overnight in TBST (0.1% Tween-20 612 (Amresco) in TBS (Corning)) at 4°C. Membranes were then blocked in TBST + 5% Bovine 613 Serum Albumin (BSA) (Amresco) for 1 hour while rocking at room temperature. Rabbit anti-614
LukA (1:50000), rabbit anti-LukS-PV (1:50000), and rabbit anti-Hla (1:50000) antibodies (62) 615
were incubated with the membranes in TBST for 1 hour. Although these antibodies recognize 616
LukA, LukS-PV, and Hla they also permit detection of Protein A due to its binding of the F C 617 region of antibodies (94). Following incubation with primary antibodies, membranes were 618 washed three times in TBST for 15 minutes and goat anti-rabbit IgG (H+L) conjugated to 619
Alkaline phosphatase (Thermo) was added at a 1:5000 dilution in TBST with 5% BSA for 1 620 hour. The membranes were washed 3 times in TBST for 15 minutes each and blots were developed with BCIP/NBT (5-bromo-4-chloro-3-indoyl-phosphate/nitro blue tetrazolium) color 622 development substrate (VWR). 623 624 AIP reporter assays. Reporter strains containing pDB59 (described above) and test strains 625 (from which conditioned media was collected) were cultured overnight in TSB supplemented 626
with Cm at 37°C with shaking at 200 rpm. The next day samples were diluted 1:100 in fresh 627 TSB and incubated for 5 hours at 37°C with shaking at 200 rpm. Samples were centrifuged at 628 4200 rpm for 10 minutes. Supernatants from test strains were collected and filter sterilized 629 through a 0.22 nm syringe filter and mixed 2:1 with fresh TSB. The reporter strain pellets were 630 then resuspended in 5 mL of the 2:1 "conditioned medium : fresh medium" mix and incubated 631
for an additional three hours. The bacteria were washed twice in 3.5 ml PBS and resuspended 632 with shaking at 200 rpm. Bacterial growth was assessed by reading OD600 followed by 645 centrifugation at 3700 rpm for 15 minutes to pellet cells. Supernatants were collected and stored at -80°C. Primary bone marrow derived macrophages (BMM) from WT, TLR2 -/-, TLR4 -/-, 647 and MyD88 -/mice were thawed and incubated at 37°C with 5% CO 2 for 48 hours before 648 seeding in a 96-well plate at 65000 cells per well. BMM were allowed to rest overnight before 649 being treated with 10 μl of thawed bacterial supernatant for 24 hours at 37°C with 5% CO 2 . 650
After 24 hours, 50 μl of supernatants were collected and stored at -80°C. To assess cytokine 651 levels, a BD TM Cytometric Bead Array Mouse Soluble Protein Set and Soluble Protein Master 652
Buffer Kit were used. The assay was conducted using the manufacturer's instructions. RBC packed cell volume. This preparation was kept on ice until use. After 6 hours, the 661 bacterial culture was centrifuged for 5 minutes at 3900 rpm. 100 µL of OD600 normalized cell-662 free supernatants were added to the top row of round bottom 96-well plates and a two-fold 663 serial dilution series was set up with these supernatants. To each supernatant dilution, 2% 664
RBCs were added (1:1) followed by incubation for 1 hour at 37°C. The plates were then 665 centrifuged for 5 minutes at 1500 rpm to pellet non-lysed RBCs, supernatants were transferred 666 to a flat bottom 96-well plate, and red blood cell lysis was measured at OD450 on a 667 spectrophotometer. 668 inoculated from freshly isolated single colonies and grown with shaking at 200 rpm at 37°C 672 overnight. The next day, a 1:100 subculture in 15 mL of TSB was incubated at 37°C for 3 673 hours with shaking. Cultures were then centrifuged for 5 minutes at maximum speed and cell 674 pellets were washed twice in 5 mL PBS. Bacterial suspensions were diluted 2 mL into 8 mL of 675 PBS and normalized with PBS to an OD600 of approximately 0.32-0.33 (1 x 10 8 CFU/mL) and 676 mixed 1:1 with sterile Cytodex beads (Sigma). Mice were deeply anesthetized with 2,2,2-677 tribromoethanol (Avertin; Sigma) via intraperitoneal injection followed by removal of fur and 678 infecting with 100 μl PBS containing 1x10 7 CFU of bacteria and Cytodex beads on the right 679 and left side by intradermal injection. Mice were monitored daily; and at 72 or 120 hours post-680 infection, they were euthanized. Skin abscesses were collected, homogenized, spread onto 681 TSA plates, and incubated overnight at 37°C in order to enumerate CFU. Skin homogenates 682 were also used for cytometric bead array analysis of local cytokine levels as described above. Acknowledgments. We thank members of the Alonzo laboratory for helpful discussions and 708
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